AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 , Confirmed to Invasive pneumococcal disease, age <5, Probable

NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 , Confirmed to Invasive pneumococcal disease, age <5, Probable  - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.
A study of quality measures for protein threading models

Background
          Prediction of protein structures is one of the fundamental challenges in biology today. To fully understand how well different prediction methods perform, it is necessary to use measures that evaluate their performance. Every two years, starting in 1994, the CASP (Critical Assessment of protein Structure Prediction) process has been organized to evaluate the ability of different predictors to blindly predict the structure of proteins. To capture different features of the models, several measures have been developed during the CASP processes. However, these measures have not been examined in detail before. In an attempt to develop fully automatic measures that can be used in CASP, as well as in other type of benchmarking experiments, we have compared twenty-one measures. These measures include the measures used in CASP3 and CASP2 as well as have measures introduced later. We have studied their ability to distinguish between the better and worse models submitted to CASP3 and the correlation between them.
        
        
          Results
          Using a small set of 1340 models for 23 different targets we show that most methods correlate with each other. Most pairs of measures show a correlation coefficient of about 0.5. The correlation is slightly higher for measures of similar types. We found that a significant problem when developing automatic measures is how to deal with proteins of different length. Also the comparisons between different measures is complicated as many measures are dependent on the size of the target. We show that the manual assessment can be reproduced to about 70% using automatic measures. Alignment independent measures, detects slightly more of the models with the correct fold, while alignment dependent measures agree better when selecting the best models for each target. Finally we show that using automatic measures would, to a large extent, reproduce the assessors ranking of the predictors at CASP3.
        
        
          Conclusions
          We show that given a sufficient number of targets the manual and automatic measures would have given almost identical results at CASP3. If the intent is to reproduce the type of scoring done by the manual assessor in in CASP3, the best approach might be to use a combination of alignment independent and alignment dependent measures, as used in several recent studies.
Compound 528015: But-2-enyl 4-nitrobenzoate

Chemical compound data from PubChem database. IUPAC Name: but-2-enyl 4-nitrobenzoate. Molecular Formula: C11H11NO4. Molecular Weight: 221.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525353: 2,2-Dimethyl-4,5-dithiaheptane

Chemical compound data from PubChem database. IUPAC Name: 1-(ethyldisulfanyl)-2,2-dimethylpropane. Molecular Formula: C7H16S2. Molecular Weight: 164.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525729: (p-Methylbenzylidene)-octyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-methylphenyl)-N-octylmethanimine. Molecular Formula: C16H25N. Molecular Weight: 231.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2013 CMHS Uniform Reporting System (URS) Table for South Carolina

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for South Carolina for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528638: Erythro-Pentonic acid, 2-deoxy-3,4,5-tris-O-(trimethylsilyl)-, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3,4,5-tris(trimethylsilyloxy)pentanoate. Molecular Formula: C17H42O5Si4. Molecular Weight: 438.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400569-T1: [Translated] 4-SUBSTITUTED 1-AMINOCYCLOHEXANE DERIVATIVES FOR USE AS ORL1 RECEPTOR AND MU-OPIATE RECEPTOR LIGANDS

Chemical patent from PubChem database. Patent Number: AT-E400569-T1. Title: Crystalline Forms of Chemical Compounds. Filing Date: 1996-04-21. Inventors: Chen, Wei, Kumar, Raj, Williams, Sarah. Abstract: The invention provides novel crystalline forms of chemical compounds, characterized by specific X-ray powder diffraction patterns and thermal properti... IPC Classifications: C07D, C07F, A61K. This patent covers 10 claims related to 5 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
4.10 Clinical/therapeutic approaches, by frequency of use: 2011. Number and percent distribution

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing clinical/therapeutic approaches, by frequency of use in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 528570: tert-Butyl(dimethyl)silyl 4-([tert-butyl(dimethyl)silyl]oxy)benzoate

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 4-[tert-butyl(dimethyl)silyl]oxybenzoate. Molecular Formula: C19H34O3Si2. Molecular Weight: 366.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Inpatient Discharges (SPARCS De-Identified): Patient Safety Indicators (PSI) Volume Measures by Hospital: Calendar Year 2015

The datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for Patient Safety Indicators generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ).

The PSIs are a set of indicators providing information on potential in hospital complications and adverse events following surgeries, procedures, and childbirth. The PSIs were developed by AHRQ after a comprehensive literature review, analysis of ICD-9-CM codes, review by a clinician panel, implementation of risk adjustment, and empirical analyses.

All PSI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) PSI measures.

The mortality, volume and utilization measures PSIs are presented by hospital as rates or counts. Area-level measures are presented by county as rates.
Compound 527729: Propanoic acid, 3-bromo-2-chloro, 3-methylbutyl ester

Chemical compound data from PubChem database. IUPAC Name: 3-methylbutyl 3-bromo-2-chloropropanoate. Molecular Formula: C8H14BrClO2. Molecular Weight: 257.55. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NCHS Research and Development Survey (RANDS) Round 2 during COVID-19 non-probability sampled Restricted File

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 2 is the second round of a three-round survey. In addition to the probability sample of RANDS during COVID-19 Round 2, the questionnaire was administered to the Dynata non-probability online opt-in sample by NORC at the University of Chicago (NORC) from August 3, 2020 to August 20, 2020.  The RANDS during COVID-19 Round 2 Non-Probability Sample does not have a known survey sampling design and cannot be used to produce nationally or sub-nationally representative estimates.
NSDUH 2020 Sample Experience Report

This report is a follow-up to the 2020 National Survey on Drug Use and Health (NSDUH)Sample Design Report. It further documents the 2020 NSDUH sample experiences by comparing expected outcomes with what actually occurred, and documenting unexpected issues that came up during the year. A summary of the sample design is included for context.Chapters:Introduces the report and summarizes the impact of the coronavirus 2019 (COVID-19) pandemic on sample design and data collection.Revisits the 2020 sample design.Documents the sample experiences at the third stage of sample selectionDocuments the sample experiences at the fourth stage of sample selectionDocuments the sample experiences at the fifth stage of sample selectionLooks at sampling error, through a computation of design effects and a comparison of observed and expected precisionExamines the Clinical Validation Study sample experience
Compound 527419: 2,7-Dimethyl-4,6-octadien-2-ol

Chemical compound data from PubChem database. IUPAC Name: 2,7-dimethylocta-4,6-dien-2-ol. Molecular Formula: C10H18O. Molecular Weight: 154.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Automated oil vapor inhalation exposure system

In August 2020 there were over 186,000 employees in the oil and gas extraction industry in the United States (United States Department of Labor. Bureau of Labor Statistics, 2020).  Many workers in the upstream oil extraction industry have potential risk of crude oil vapor (COV) inhalation.  There are many current knowledge gaps regarding the health effects from inhalation of complex mixtures found in crude oil vapors.  To aid research in filling these gaps, an automated system that could carefully deliver and control the COV concentration within an animal inhalation exposure chamber was needed.  The objective of this project was to develop an automated computer-controlled system to expose small laboratory animals to precise concentrations of crude oil vapor (COV).
Patent AT-E400224-T1: [Translated] DEVICE FOR PLACING A CUTTING BLOCK FOR A RESECTION OF THE TIBIA

The device has a transverse arm (5) that is anchored at a tibia platform that is connected to the device so that a transaction block (2) is adjusted relative to the arm`s height on a straight line guide. A joint arrangement is provided for the guide to realize different relative positions between the guide, arm and device. The arrangement has two swiveling axes that are oriented in anterior and mid lateral directions, respectively.
Chicago: Drug-Related Emergency Department Visits, 2004-2011 - Accidental Ingestions

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving accidental ingestions in the Chicago metropolitan area. This analytic category includes ED visits in which an individual accidentally or unknowingly used or was administered a prescription drug, over-the-counter medication, or dietary supplement. Drug-related accidental ingestion typically involves patients aged 5 and under.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 528691: Serotonin, TMS

Chemical compound data from PubChem database. IUPAC Name: N-trimethylsilyl-2-(1-trimethylsilyl-5-trimethylsilyloxyindol-3-yl)ethanamine. Molecular Formula: C19H36N2OSi3. Molecular Weight: 392.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528366: (R,S)-N-Nitroso Anatabine

Chemical compound data from PubChem database. IUPAC Name: 3-(1-nitroso-3,6-dihydro-2H-pyridin-2-yl)pyridine. Molecular Formula: C10H11N3O. Molecular Weight: 189.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 CMHS Uniform Reporting System (URS) Output Tables for Republic of Palau

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Risk factors for breast cancer in Iran: a case-control study

Background
          Iranian breast cancer patients are relatively younger than their Western counterparts. The objective of the present study was to investigate risk factors for breast cancer in Iranian women.
        
        
          Method
          A case-control study was conducted from April 1997 to April 1998 in Tehran, Iran. Demographical data and risk factor related information were collected using a short structured questionnaire. Odds ratios (ORs) and 95% confidence intervals (CIs) were derived from logistic regression analysis.
        
        
          Results
          In all, 286 women with breast cancer and 249 control women were interviewed. In multivariate analysis, only marital status (never married: OR 4.24, 95% CI 1.70-10.57 [P = 0.002]; widowed/divorced: OR 1.71, 95% CI 1.05-2.68 [P = 0.03]) and family history (positive family history of breast cancer: OR 2.95, 95% CI 1.15-7.59 [P = 0.02]) were associated with significantly increased risk for breast cancer.
        
        
          Conclusion
          The findings of the present study suggest that family history and marital status may have an impact on the incidence of breast cancer in Iranian women.
FY 2003 Children's Bureau Competitive Discretionary Grant Awards

This document provides a list of Children's Bureau discretionary grants and cooperative agreements awarded in fiscal year 2003:

2003A: Adoption Opportunities Demonstration Activities (CFDA # 93.652)
(approximately $7,144,337)

2003A.1 Adoptive Placements for Children in Foster Care - up to $350,000/yr each for 5 years

2003A.2 Projects to Improve Recruitment of Adoptive Parents in Rural Communities - up to $400,000/yr each for 5 years

2003A.3 Developing a National Network of Adoption Advocacy Programs 
up to $250,000 each in year one for planning and up to $500,000 each for years 2-5

2003A.4 Administration of the Interstate Compact on Adoption and Medical Assistance (ICAMA) 
up to $200,000/yr each for 5 years

2003B: Child Abuse and Neglect Discretionary Activities (CFDA # 93.670) - (approximately $7,363,379)

2003B.1 Fellowships for University-Based Doctoral Candidates and Faculty for Investigator-Initiated Research in Child Abuse and Neglect - up to $130,000 each for 2 years

2003B.2 Improving Child Welfare Outcomes through Systems of Care
up to $500,000/yr each for 5 years

2003D.1 Replication of Demonstrated Effective Practices in the Prevention of Child Abuse and Neglect - up to $175,000 each in year one for planning, and up to $350,000 each in years 2-5

2003D.2 Evaluations of Existing Child Abuse and Neglect Prevention Programs
up to $200,000/yr each for 3 years

2003C: Child Welfare Training Project Activities (CFDA # 93.648)
(approximately $4,906,732)

2003C.1 Professional Education for Public Child Welfare Practitioners:

2003C.1A: Professional Education for Prospective MSW Level Public Child Welfare Staff (Awarding MSW Degree) - up to $75,000/yr each for 4 years

2003C.1B: Professional Education for Current Public Child Welfare Agency Staff (Awarding BSW and/or MSW Degree) - up to $75,000/yr each for 5 years

2003C.1C: Professional Education for Prospective and Current American Indian and or/ Alaskan Native Public Child Welfare Staff who are currently enrolled or plan to enroll in BSW or MSW Social Work Programs (Awarding BSW and /or MSW Degree) - up to $$75,000/yr each for 5 years

2003C.2 Training for Effective Child Welfare Practice in Rural Communities - up to $200,000/yr each for 5 years

2003C.3 Developing Models of Effective Child Welfare Staff Recruitment and Retention Training - up to $200,000/yr each for 5 years

2003C.4 Training for Healthy Marriage and Family Formation - up to $200,00/yr each for 5 years

2003C.5 National Evaluation of Child Welfare Training Grants - up to $350,000/yr each for 3 years

2003D: Promoting Safe and Stable Families Activities CFDA # 93.556 - approximately $2,346,871

2003.D1 and 2003.D2 are located under CFDA # 93.670, 2003.B

2003D.3 Evaluations of Existing Family Support, Family Preservation, Reunification, or Adoption Promotion and Support Programs - up to $200,000/yr each for 3 years

2003D.4 Projects to Develop Programs to Strengthen Marriages
up to $200,000/yr each for 3 years

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527398: 12-Tridecen-2-yl acetate

Chemical compound data from PubChem database. IUPAC Name: tridec-12-en-2-yl acetate. Molecular Formula: C15H28O2. Molecular Weight: 240.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401046-T1: [Translated] ORTHODIC INLAY

Orthotic inlay ( 59 ) for arrangement in a supporting shell configuration of an orthotic device for a body part having a molded cushion ( 10 ) for shaping to the body part with at least one cushion chamber designed in an airtight casing, said chamber being evacuable via a valve mechanism ( 48 ) and having a molded body filling consisting of a plurality of molded bodies and having a molded cushion casing ( 49 ) to accommodate the molded cushion, whereby the molded cushion ( 10 ) has a planar cushion blank, and after being accommodated in the respective receptacle areas of the molded cushion casing side parts ( 28, 29 ) and a strap part ( 16 ) of the molded cushion form a shell-shaped body part receptacle for enclosing at least a portion of the body part that is to be accommodated.
A direct method to visualise the aryl acylamidase activity on cholinesterases in polyacrylamide gels

Background
          In vertebrates, two types of cholinesterases exist, acetylcholinesterase and butyrylcholinesterase. The function of acetylcholinesterase is to hydrolyse acetylcholine, thereby terminating the neurotransmission at cholinergic synapse, while the precise physiological function of butyrylcholinesterase has not been identified. The presence of cholinesterases in tissues that are not cholinergically innervated indicate that cholinesterases may have functions unrelated to neurotransmission. Furthermore, cholinesterases display a genuine aryl acylamidase activity apart from their predominant acylcholine hydrolase activity. The physiological significance of this aryl acylamidase activity is also not known. The study on the aryl acylamidase has been, in part hampered by the lack of a specific method to visualise this activity. We have developed a method to visualise the aryl acylamidase activity on cholinesterase in polyacrylamide gels.
        
        
          Results
          The o-nitroaniline liberated from o-nitroacetanilide by the action of aryl acylamidase activity on cholinesterases, in the presence of nitrous acid formed a diazonium compound. This compound gave an azo dye complex with N-(1-napthyl)-ethylenediamine, which appeared as purple bands in polyacrylamide gels. Treating the stained gels with trichloroacetic acid followed by Tris-HCl buffer helped in fixation of the stain in the gels. By using specific inhibitors for acetylcholinesterase and butyrylcholinesterase, respectively, differential staining for the aryl acylamidase activities on butyrylcholinesterase and acetylcholinesterase in a sample containing both these enzymes has been demonstrated. A linear relationship between the intensity of colour developed and activity of the enzyme was obtained.
        
        
          Conclusions
          A novel method to visualise the aryl acylamidase activity on cholinesterases in polyacrylamide gels has been developed.